Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscripts
出版年份 2019 全文链接
标题
Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscripts
作者
关键词
-
出版物
PLoS One
Volume 14, Issue 10, Pages e0222359
出版商
Public Library of Science (PLoS)
发表日期
2019-10-23
DOI
10.1371/journal.pone.0222359
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
- (2018) Diana Miao et al. SCIENCE
- Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles
- (2017) Peggy Sekula et al. PLoS One
- Increasing value and reducing waste in biomedical research: who's listening?
- (2016) David Moher et al. LANCET
- Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma
- (2016) H. Matsushita et al. Cancer Immunology Research
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Reducing waste from incomplete or unusable reports of biomedical research
- (2014) Paul Glasziou et al. LANCET
- Biomedical research: increasing value, reducing waste
- (2014) Malcolm R Macleod et al. LANCET
- Improving the Transparency of Prognosis Research: The Role of Reporting, Data Sharing, Registration, and Protocols
- (2014) George Peat et al. PLOS MEDICINE
- External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
- (2013) Daniel YC Heng et al. LANCET ONCOLOGY
- Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research
- (2013) Richard D. Riley et al. PLOS MEDICINE
- Why Your New Cancer Biomarker May Never Work: Recurrent Patterns and Remarkable Diversity in Biomarker Failures
- (2012) S. E. Kern CANCER RESEARCH
- Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting
- (2012) Lisa M. McShane et al. JOURNAL OF CLINICAL ONCOLOGY
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
- (2012) Douglas G. Altman et al. PLOS MEDICINE
- Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
- (2011) Maxine Sun et al. EUROPEAN UROLOGY
- Biospecimen Reporting for Improved Study Quality (BRISQ)
- (2011) Helen M. Moore et al. JOURNAL OF PROTEOME RESEARCH
- CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
- (2011) Kenneth F. Schulz et al. International Journal of Surgery
- Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
- (2009) S Mallett et al. BRITISH JOURNAL OF CANCER
- Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis and beyond
- (2009) R D Riley et al. BRITISH JOURNAL OF CANCER
- Tumor Size is a Determinant of the Rate of Stage T1 Renal Cell Cancer Synchronous Metastasis
- (2009) Giovanni Lughezzani et al. JOURNAL OF UROLOGY
- Blood Markers for the Prognosis of Ischemic Stroke
- (2009) William Whiteley et al. STROKE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More